230
230
Mar 2, 2013
03/13
by
CNBC
tv
eye 230
favorite 0
quote 0
bristol meyers.stock won't be impacted no matter what we hear from the president or speaker or anyone with a microphone. it seems with the intention of scaring us and driving things lower with apocalyptic chatter. i always try to find myself trying to figure out what stocks are indeed affected. as usual, there is a dearth of stocks that should be number one really, the public enemy number one of the stock market. because there's got to be some impact to the defense sector, right? doesn't there? but then again, the defense stocks index keeps hitting an all-time high. i think what the bears got wrong here is they didn't have a security that could be crushed purely off the sequester. nothing complied. so they got to create one. there is something you ponder over the weekend. from the looks of this market, the sequestration doesn't have enough relation to the profits of companies or the stocks themselves to allow the short sellers to get the just desserts they feel entitled to. sorry, get us something to
bristol meyers.stock won't be impacted no matter what we hear from the president or speaker or anyone with a microphone. it seems with the intention of scaring us and driving things lower with apocalyptic chatter. i always try to find myself trying to figure out what stocks are indeed affected. as usual, there is a dearth of stocks that should be number one really, the public enemy number one of the stock market. because there's got to be some impact to the defense sector, right? doesn't there?...
563
563
Mar 22, 2013
03/13
by
CNBC
tv
eye 563
favorite 0
quote 0
utility, bristol-meyers is one of my action alerts charitable trust names.ondeliz is a food company. verizon is telco, oil, food, drug and utility. can i say that is a perfect combination -- this portfolio it's got great companies. i'm not that concerned about bp's trial at this point. this is a model portfolio if bp wins. it's not a model portfolio if bp loses, but i like it very much. richard in a place we visited for one of our college shows, richard in iowa. >> caller: boo-yah to you, jimmy. >> nice. >> caller: from the hawkeye state overlooking the mississippi. how are you doing today? >> i'm having a real good day. how about you? >> caller: i am, too. i wanted to give a that a girl to one of your people that works for you, heather. she is a swell gal. >> you like heather? yeah, she's long tall sally. she went to the u of which i think you ought to watch that 30 for 30. get a little intel about the u. i'm sorry. >> caller: okay. dendreon, dndn, ford, zynga, financial select xll and zeotis. >> let me go to work. i know heather is smiling back there. toil
utility, bristol-meyers is one of my action alerts charitable trust names.ondeliz is a food company. verizon is telco, oil, food, drug and utility. can i say that is a perfect combination -- this portfolio it's got great companies. i'm not that concerned about bp's trial at this point. this is a model portfolio if bp wins. it's not a model portfolio if bp loses, but i like it very much. richard in a place we visited for one of our college shows, richard in iowa. >> caller: boo-yah to you,...
217
217
Mar 25, 2013
03/13
by
CNBC
tv
eye 217
favorite 0
quote 0
as bristol-meyers is your classic defensive big pharma stock, company is going to keep growing no madderow badly the europeans screw up things because people always need their medicine. frankly, i think it's accelerating its growth. it's time to update this dictum to keep up with the times, old dog, new tricks. the big pharma stocks have been on a real roll lately. i like before it toll myers we owe it for our charitable trust. when i started screaming what that had to do with the price-to-ratios, it was the heyday when the major companies were growth juggernauts and their stocks were valued accordingly. let's take 1998, your typical big pharma stock traded 30 to 40 times earnings. these days they trade in the low teens or even lower. many trade like fixed income vehicles. most of the huge blockbuster drugs from the '90s have gone off patent. they lost that spark of innovation that made their stocks such power houses back in days of yore. so all this week, i want to go where the innovation is. i want to find the companies that could be the next gigantic pharma names. some already are. th
as bristol-meyers is your classic defensive big pharma stock, company is going to keep growing no madderow badly the europeans screw up things because people always need their medicine. frankly, i think it's accelerating its growth. it's time to update this dictum to keep up with the times, old dog, new tricks. the big pharma stocks have been on a real roll lately. i like before it toll myers we owe it for our charitable trust. when i started screaming what that had to do with the...
70
70
Mar 1, 2013
03/13
by
CNBC
tv
eye 70
favorite 0
quote 0
dow jones reporting that bristol meyers weighed large possible acquisitions. deals for biogen and shire. dow jones saying bristol meyers continued to explore potential acquisitions. we will keep you updated as we get more news. mandy, back to you. >> thank you very much, josh. >>> british government is selling wine at about $7500 a bottle. to cover the cost of maintaining the country's official wine seller. which contains, by the way, more than 38,000 bottles. but another brit is making big money on wine, not by selling it, but by taking it as collateral for loans. veteran wine drinker, jane wells, reports he is making lots of dough off that, right, jane? >> i don't think there is any merlot in there but he has made lemonade out of lemons or wine out of raisins. he found a a revenue stream against wines around the world. >> close of a hundred thousand pounds worth of wine here. >> burton's company, makes loans for 35% of the market value of the wine put in hawk. he made 200 loans totaling $30 million. interest rates on these loans is 15%. he passes through 12%
dow jones reporting that bristol meyers weighed large possible acquisitions. deals for biogen and shire. dow jones saying bristol meyers continued to explore potential acquisitions. we will keep you updated as we get more news. mandy, back to you. >> thank you very much, josh. >>> british government is selling wine at about $7500 a bottle. to cover the cost of maintaining the country's official wine seller. which contains, by the way, more than 38,000 bottles. but another brit is...
149
149
Mar 1, 2013
03/13
by
CNBC
tv
eye 149
favorite 0
quote 0
>> joe mentioned healthcare within i'm going with bristol meyer. >> i'm looking at casualty insurancerape. travellers. xl group. >> steve? >> verizon. still think it's solid. >> have a great weekend. "power" starts right now. >> this is a special edition of "power lunch." one tough week. it's been a rough seven days for many of the biggest names in business. and the biggest names in washington. >> he has got to go. >> jc penney's ron johnson fighting for his ceo ship and courtroom battle against macy's. the prize, martha stewart? >> you don't like it, you're fired. >> will he be next to hear -- >> you're fired. >> then bill ackman. vanity fair going after him. and his drive outside of the office. oh, and washington. >> a shame our republican colleagues have decided to protect special interest. >> how much more money do we want to steal from the american people. >> the uncertainty is already having an affect. companies are preparing layoff notices. >> a special edition of "power lunch," one tough week, begins right now. >> and welcome. i'm scott wapner in for sue and tyler today. this
>> joe mentioned healthcare within i'm going with bristol meyer. >> i'm looking at casualty insurancerape. travellers. xl group. >> steve? >> verizon. still think it's solid. >> have a great weekend. "power" starts right now. >> this is a special edition of "power lunch." one tough week. it's been a rough seven days for many of the biggest names in business. and the biggest names in washington. >> he has got to go. >> jc...
151
151
Mar 28, 2013
03/13
by
CNBC
tv
eye 151
favorite 0
quote 0
built on the gains and new highs for things like health care, for names like johnson & johnson, bristol meyerss. these are defensive names, they're not materials, they're not technology. >> on the other hand though, fact of the matter, are you talking s&p. that's a pretty broad metric right now. you have to give this market its due. nonetheless with the volume being muted here today and trading not that much alacrity in the trading. we'll have the end of the quarter liquidity events so it will get busy. generally it is muted during the day and gets very active near the end of the day. but they won't sell them on the last day of the quarter. that's not the way the game is played these days. >> we have a lot of events next week overseas. we'll continue to watch the cyprus fallout and whether or not the bank lines continue but also bank of gentleman man meets next week. this could be a huge factor in the floebl markets. >> it could be but actually at this point guys are saying that the business to be is in mints. i think everybody's sort of staying the same course globally, whether japan or wheth
built on the gains and new highs for things like health care, for names like johnson & johnson, bristol meyerss. these are defensive names, they're not materials, they're not technology. >> on the other hand though, fact of the matter, are you talking s&p. that's a pretty broad metric right now. you have to give this market its due. nonetheless with the volume being muted here today and trading not that much alacrity in the trading. we'll have the end of the quarter liquidity...